Excelya homepage
  • About us
    • Who we are
    • Where to find us
    • Leadership Team
    • Sustainability & CSR
    • Meet us / 2026 Events
  • Operating Solutions
    • Full Service
    • Functional Service Provider (FSP)
    • Clinical Resourcing
  • Scientific Services
    • Clinical Operations
    • Data Management
    • Statistics & Programming
    • Pharmacovigilance & Safety
    • Medical Affairs
    • eTMF Management
    • Regulatory Affairs
    • Quality Assurance
  • Therapeutic & Speciality Areas
    • Oncology & Hematology
    • Rare Disease & Pediatrics
    • Inflammation & Immunology
    • Infectious Disease
    • Pain Treatment & CNS
    • Late Phase & RWE
  • Resources
    • Case Studies
    • Blogs
    • Excelyate Publications
    • Press Releases
    • FAQs
  • Careers
  • EN
    • FR
    • Submit an RFP
Excelya homepage
  • About us
    • Who we are
    • Where to find us
    • Leadership Team
    • Sustainability & CSR
    • Meet us / 2026 Events
  • Operating Solutions
    • Full Service
    • Functional Service Provider (FSP)
    • Clinical Resourcing
  • Scientific Services
    • Clinical Operations
    • Data Management
    • Statistics & Programming
    • Pharmacovigilance & Safety
    • Medical Affairs
    • eTMF Management
    • Regulatory Affairs
    • Quality Assurance
  • Therapeutic & Speciality Areas
    • Oncology & Hematology
    • Rare Disease & Pediatrics
    • Inflammation & Immunology
    • Infectious Disease
    • Pain Treatment & CNS
    • Late Phase & RWE
  • Resources
    • Case Studies
    • Blogs
    • Excelyate Publications
    • Press Releases
    • FAQs
  • Careers
  • EN
    • FR
Submit your request

Blog

Excelya at Patient Safety Congress 2026 in Amsterdam

ISS & ISE: How Integrated Clinical Summaries Drive FDA Approval

Prediction Markets and Clinical Trials: Risk to trial Integrity

Ipsen and Excelya: Clinical Research Partnership

Real-world data quality framework illustrating interconnected healthcare data sources used to generate reliable real-world evidence for regulatory and clinical decision-making.

How to Assess Real-World Data Quality Before Starting Your RWE Study

Illustration representing AI in clinical biostatistics, combining clinical data analytics, genomics, biometrics, predictive modeling, and artificial intelligence for clinical development.

AI in Clinical Biostatistics: The Turning Point Is Here

Audience attending a presentation during the PSI 2026 Conference in Belfast.

Excelya at PSI 2026 Conference: Clinical Statistics Insights

Audience watching a Pharmacovigilance Europe 2026 session on safety reporting timelines.

Excelya at PV Europe 2026: Drug Safety Insights

Mains tenant des pièces de puzzle pour le partenariat de pharmacovigilance Excelya UCB.

10 Years of Pharmacovigilance Partnership: Excelya and UCB

Abstract data visualization representing Bayesian methods in clinical trials and adaptive study design.

Bayesian Methods in Clinical Trials: FDA 2026 Guidance Matters 

Posts pagination

Page 1 Page 2 … Page 6 Next page
Excelya homepage

Excelya is proud to be a premium global CRO, headquartered in Europe.

Excelya Swiss approval ISO 27001:2023 certification badge confirming information security and data protection compliance.
Excelya EcoVadis Bronze sustainability rating certification, ranked Top 35% globally, valid until January 2026.
Excelya official Veeva Services Partner certification badge for life sciences consulting and technology services.

Head office

Excelya
35 rue de Paris
92100 Boulogne Billancourt

We are Social


Facebook


Instagram


LinkedIn


YouTube

Discover

  • About us
  • Capabilities
  • Therapeutic Areas
  • Our Solutions
  • Careers
  • Data Protection Notice
  • Cookie Notice
  • Legal Notice

Stay Updated with Excelya


© 2026 Excelya. All rights reserved. © 2026 Excelya. Tous droits réservés.